Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Cellular and molecular mechanisms of photobiomodulation: A scoping review on therapeutic potential for multiple sclerosis

The synthesized evidence confirms the remarkable therapeutic potential of PBM in multiple sclerosis.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This scoping review synthesized preclinical and clinical studies on photobiomodulation for multiple sclerosis to map its proposed mechanisms, such as mitochondrial, antioxidant and anti-inflammatory effects. The authors report that photobiomodulation was associated with these mechanistic changes and describe the evidence as supporting therapeutic potential. The abstract does not give study counts or wavelengths, and it does not state how strong or consistent the evidence is.

Who or what was studied
Multiple sclerosis; animal and human clinical models
Limits stated in the abstract
The abstract does not report included study numbers, wavelengths, dosing or certainty of evidence, and the mechanisms are described as incompletely elucidated.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Other

Effect of 460 nm blue light PBM on human MeWo melanoma cells

Although the cells initially attempt to resist the stress induced by the treatment, they eventually undergo apoptosis over time. These findings contribute to understanding melanoma's molecular response to blue light PBM, lay the groundwork for future clinical applications.

Study · June 27, 2024 · Qin H et al.